REVIEW ARTICLE
Year : 2023 | Volume
: 16 | Issue : 1 | Page : 13--29
A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress
Sumel Ashique1, Shubneesh Kumar1, Himanshu Kumar1, Jayita Roy2, Soumen Pal3, Swagata Pal4
1 Department of Pharmaceutics, Bharat Institute of Technology, School of Pharmacy, Meerut, Uttar Pradesh, India
2 Department of Pharmaceutics, Radha Govind University, Radha Govind Nagar, Lalki Ghati, Jharkhand, Ramgarh, India
3 Department of Pharmacy, Meerut Institute of Technology (MIT), NH 58, Baral Partapur, Meerut, Uttar Pradesh, India
4 Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences and Research, BASU, Gandhar Sarani, Bidhannagar, Durgapur, West Bengal, India
Correspondence Address:
Asst. Prof. Sumel Ashique
Department of Pharmaceutics, Bharat Institute of Technology, School of Pharmacy, Meerut - 250 103, Uttar Pradesh
India
Even if many countries are against it since vaccinations are not readily available, industrialized countries continue to make some vaccines designated under the World Health Organization's emergency use listing mandatory for entry into their countries. The first half of 2021 has seen the introduction of SARS-CoV-2 vaccinations in several countries, after the exceptional speed of vaccine development and testing in 2020. Using keywords in online databases such as Pubmed, Scopus, Web of Science, Cochrane, and Embase, this systematic search was carried out. The findings were collected into a report. We were unable to do an adequate human study because we included so many different kinds of vaccinations. A look at current vaccination-controlled trials and actual facts on immunization success is also presented. The efficacy of new vaccines is continually being tested in ongoing vaccine trials. Increasing the alternatives for global vaccine production to manufacture sufficient vaccine shots for international usage and to enhance the statistics for the potential utility of various vaccination platforms in forthcoming pandemics are also a result of this.
How to cite this article:
Ashique S, Kumar S, Kumar H, Roy J, Pal S, Pal S. A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress.Indian J Health Sci Biomed Res 2023;16:13-29
|
How to cite this URL:
Ashique S, Kumar S, Kumar H, Roy J, Pal S, Pal S. A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress. Indian J Health Sci Biomed Res [serial online] 2023 [cited 2023 Mar 23 ];16:13-29
Available from: https://www.ijournalhs.org/article.asp?issn=2542-6214;year=2023;volume=16;issue=1;spage=13;epage=29;aulast=Ashique;type=0 |
|
